In the latest trading session, Cathie Wood’s ARK ETFs have made notable adjustments to their holdings, with Airbnb Inc (NASDAQ:ABNB) leading the purchases and Palantir Technologies Inc (NYSE:NASDAQ:PLTR) witnessing a significant sell-off. ARK’s flagship ARKK ETF acquired a substantial 214,624 shares of Airbnb, totaling a value of approximately $29.63 million, marking the largest dollar-value trade for the day.
The daily trade report for Wednesday, 14 May 2025, shows that ARK’s investment strategies continue to adapt to the evolving market landscape. Alongside Airbnb, ARK’s ARKF ETF bolstered its position in eToro Group Ltd (NASDAQ:ETOR), adding 140,000 shares worth around $7.28 million. This move indicates ARK’s growing confidence in the social trading platform.
Another notable buy includes CRISPR Therapeutics AG (NASDAQ:CRSP), with ARKK ETF purchasing 31,983 shares, reflecting a continued investment in the gene-editing company with a total dollar value of about $1.19 million. The consistent buying pattern in CRISPR Therapeutics over the past week underscores ARK’s bullish stance on the biotech sector.
On the sell side, ARK’s ARKK ETF reduced its stake in Palantir Technologies, offloading 206,881 shares valued at roughly $26.5 million. This trade represents the most significant sale by dollar value for the day. In addition, ARK divested 132,149 shares of UiPath Inc (NYSE:PATH) through its ARKF ETF, amounting to approximately $1.75 million.
Other transactions include the purchase of 22471 shares of GitLab Inc (NASDAQ:GTLB) through ARKW ETF, with a total dollar value of $1.19 million, and the acquisition of 550,000 shares of 3IQ Solana Staking ETF across ARKW and ARKF ETFs, indicating ARK’s interest in cryptocurrency-related assets.
Smaller trades involved Blade Air Mobility Inc (NASDAQ:BLDE), Nextdoor Holdings Inc (NYSE:KIND), and Twist Bioscience Corp (NASDAQ:TWST), among others, reflecting ARK’s strategy to diversify and tap into emerging technology and biotechnology sectors.
Investors following ARK’s movements will note the ETF’s recent pattern of accumulating shares in GitLab Inc and CRISPR Therapeutics, suggesting a strategic focus on these companies. Conversely, the consistent selling of Palantir shares could signal a shift in ARK’s long-term outlook for the data analytics firm.
As market dynamics shift, Cathie Wood’s ARK ETFs continue to reallocate resources, giving investors a glimpse into the investment firm’s perspective on future growth opportunities and risks.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.